[…] decades and the term is becoming increasingly inaccurate. A few so-called undruggable targets, such as Bcl-2 and RAS, have been successfully targeted with clinically approved inhibitors. Therefore, “difficult to drug” […]
Monoclonal antibody directed against both isoforms of BCL-2 protein.
Damage to the Bcl-2 gene has been identified as a cause of a number of cancers, including melanoma, breast, prostate, chronic lymphocytic leukemia, and lung cancer, and a possible cause […]
Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2
Monoclonal antibody which binds anti-apoptotic regulator BCL2, used to aid in differentiating between various lymphomas and as prognostic biomarker in various cancers.
[…] the nucleus and the cytoplasm. Overexpression of BCLAF1 promotes apoptosis by preventing the transcription of Bcl-2. Bcl-2 is one of many key regulators of apoptosis which are essential for development, […]
![Immunohistochemistry using anti-p53 [V5P4H6*B3] on a Zebrafish embryo.](https://cancertools.org/wp-content/uploads/4cba5645-9492-4a6a-aabd-55f0dfe6606b.png)
[…] be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over. Isoform 2 enhances the transactivation activity of isoform […]
[…] lymph nodes through apoptosis which is further mediated by a lower regulation of the gene Bcl-2._x000D_ _x000D_ PD-L1 binds to its receptor, PD-1, found on activated T cells, B cells, […]
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
